Skip to main content
REGN
NASDAQ Life Sciences

Regeneron Forms Radiopharma Partnership with Telix, Potentially Worth Over $2.1 Billion

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$749.36
Mkt Cap
$79.158B
52W Low
$476.487
52W High
$821.11
52W Position info
57% above low
Off High info
8.7% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

REGN sits 57% above its 52-week low of $476.487.

Summary

Regeneron Pharmaceuticals has announced a strategic radiopharmaceutical partnership with Australia's Telix Pharmaceuticals. The collaboration involves co-developing and co-commercializing therapies, with costs and profits split equally. Telix will receive an upfront payment of $40 million for four initial programs, with the agreement potentially reaching over $2.1 billion in development and commercial milestone payments plus low double-digit royalties. This partnership expands Regeneron's pipeline into the radiopharmaceutical space, leveraging Telix's development and manufacturing capabilities with Regeneron's antibody discovery platforms. This is a material strategic move that could drive future growth and diversify Regeneron's therapeutic offerings.

At the time of this announcement, REGN was trading at $749.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $79.2B. The 52-week trading range was $476.49 to $821.11. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

REGN - Latest Insights

REGN
Nov 08, 2026, 4:00 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $900.00
Real-time Price: $950.03 info
Change: +$50.03 (+6%) info
Market Cap: $98.825B info
REGN
Oct 30, 2026, 12:34 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $910.52
Real-time Price: $950.03 info
Change: +$39.51 (+4%) info
Market Cap: $98.825B info
REGN
Oct 30, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $856.00
Real-time Price: $950.03 info
Change: +$94.03 (+11%) info
Market Cap: $98.825B info
REGN
Oct 30, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $835.00
Real-time Price: $950.03 info
Change: +$115.03 (+14%) info
Market Cap: $98.825B info
REGN
Oct 12, 2026, 12:06 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $764.45
Real-time Price: $950.03 info
Change: +$185.58 (+24%) info
Market Cap: $98.825B info